Exosomes as Tools to Suppress Primary Brain Tumor (Q38777386)

6 September 2017

title

Exosomes as Tools to Suppress Primary Brain Tumor (English)

1 reference

6 September 2017

2

Michael Chopp

1 reference

6 September 2017

Mark Katakowski

1

1 reference

6 September 2017

publication date

17 March 2016

1 reference

Cellular and Molecular Neurobiology

6 September 2017

published in

1 reference

6 September 2017

volume

36

1 reference

6 September 2017

issue

3

1 reference

6 September 2017

page(s)

343-352

1 reference

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Tumor-derived exosomes: a new source of tumor rejection antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

A miRNA signature for defining aggressive phenotype and prognosis in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Prostate cancer vaccines: the long road to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome from chaperone-rich cell lysates-loaded dendritic cells produced by CELLine 1000 culture system exhibits potent immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Targeting cancer stem cells for treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Ectosomes and exosomes: shedding the confusion between extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome-mediated delivery of siRNA in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Cellular internalization of exosomes occurs through phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Human glioma growth is controlled by microRNA-10b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

The majority of microRNAs detectable in serum and saliva is concentrated in exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Proteomic and immunologic analyses of brain tumor exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Glioma stem cell maintenance: the role of the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

microRNA involvement in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes in tumor microenvironment influence cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Functional MicroRNA Is Transferred between Glioma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

MiR-146b-5p Suppresses EGFR Expression and ReducesIn VitroMigration and Invasion of Glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Body fluid derived exosomes as a novel template for clinical diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes for drug delivery - a novel application for the mesenchymal stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Cell biology. No ESCRTs for exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes: extracellular organelles important in intercellular communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes as a potential tool for a specific delivery of functional molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

MicroRNA involvement in brain tumors: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Comprehensive analysis of microRNA expression profile in malignant glioma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Horizontal transfer of RNAs: exosomes as mediators of intercellular communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Extracellular vesicles: exosomes, microvesicles, and friends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

B lymphocytes secrete antigen-presenting vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Loss of heterozygosity for 10q loci in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

microRNAs in gliomas: small regulators of a big problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Intratumoral immunotherapy for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Biodistribution and delivery efficiency of unmodified tumor-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Potential of cancer cell-derived exosomes in clinical application: a review of recent research advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

The many roles of microRNAs in brain tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

The role of microRNAs in glioma initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0280-9

Exosomes: secreted vesicles and intercellular communications

21 January 2018

1 reference

12 December 2020

Exosomal miRNAs: Biological Properties and Therapeutic Potential

1 reference

12 December 2020

Exosome: from internal vesicle of the multivesicular body to intercellular signaling device

1 reference

12 December 2020

Modulation of B-cell exosome proteins by gamma herpesvirus infection

1 reference

12 December 2020

Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.

1 reference

12 December 2020

Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy

1 reference

12 December 2020

Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment

1 reference

12 December 2020

Tumour-derived exosomes: Tiny envelopes for big stories.

1 reference

12 December 2020

A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy

1 reference

12 December 2020

Functions and therapeutic roles of exosomes in cancer.

1 reference

12 December 2020

Exome Sequencing to Predict Neoantigens in Melanoma.

1 reference

12 December 2020

Exosomes/miRNAs as mediating cell-based therapy of stroke

1 reference

12 December 2020

Functions and application of exosomes.

1 reference

12 December 2020

Exosome mimetics: a novel class of drug delivery systems

1 reference

12 December 2020

Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum

1 reference

12 December 2020

The roles of tumor-derived exosomes in cancer pathogenesis

1 reference

12 December 2020

Analysis of the functional role of chromosome 10 loss in human glioblastomas.

1 reference

12 December 2020

Evaluation of intratumoral administration of tumor necrosis factor-alpha in patients with malignant glioma.

1 reference

12 December 2020

Intercellular communication: diverse structures for exchange of genetic information

1 reference

12 December 2020

10.1007/S10571-015-0280-9

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1042719391

0 references

1 reference